Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC2747 Irl-1620
ET B receptor agonist, showing anti-apoptotic activity and protecting neural cells in rats with cerebral ischemia
More description
DCC2746 ire1-in-vii
Inhibitor of IRE1 endoribonuclease activity, strongly inhibiting XBP-1 splicing in an in vivo model of acute endoplasmic reticulum stress.
More description
DCC2745 Irc-083864
Novel inhibitor of CDC25 phosphatases, actively against human cancer cells
More description
DCC2744 Irak4-in-13
Novel Orally Efficacious IRAK4 Inhibitor, Targeting MyD88L265P Mutant Diffuse Large B Cell Lymphoma
More description
DCC2743 Irak3 Degrader 23
Novel potent and selective degrader of IRAK3, inducing proteasome-dependent degradation of IRAK3 and showing both CRBN and IRAK3 binding for activity
More description
DCC2742 Irak Inhibitor 3
Novel interleukin-1 (IL-I) receptor-associated kinase (IRAK) modulator
More description
DCC2741 Ir-1061
NIR-II cyanine dye for cancer treatment and diagnosis
More description
DCC2740 Iqs-01.01rs
Novel potent inverse agonist of the chemokine receptor CXCR4, preventing CXCL12-mediated chemotaxis and triggering apoptosis in a panel of 18 cell lines and primary cultures, with superior mobilizing properties in vivo
More description
DCC2739 Ipsalazide
Sulfasalazine analog, releasing 5-aminosalicylic acid and a nontoxic carrier molecule in the gastrointestinal tract
More description
DCC2738 Ips-02001
Novel inhibitor of protein-protein interaction (PPI), targeting integrin αvβ3-osteopontin interface, blocking OC maturation from murine bone marrow-derived macrophages, as well as the resorptive function of OCs, impairing downstream signaling of integrin
More description
DCC2737 Iproclozide
Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI)
More description
DCC2736 ipr-456
Inhibitor of the uPAR·uPA protein-protein interaction, blocking cancer cell invasion
More description
DCC2735 Ipr-2025
Novel inhibitor of glioblastoma multiforme (GBM), inhibiting cell viability of low-passage patient-derived GBM spheroids, blocking tube-formation of endothelial cells in Matrigel, showing no effect on primary hematopoietic CD34+ progenitor spheroids or as
More description
DCC2734 Ipomoeassin F
Natural inhibitor of the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor, binding Sec61α to Inhibit Protein Translocation
More description
DCC2733 Ipomeamarone
Natural toxic furanoterpenoid found in mold-damaged sweet potatoes
More description
DCC2732 Ipi-269609
Orally bioavailable inhibitor of Hedgehog signaling, inhibiting tumor initiation and metastasis in pancreatic cancer
More description
DCC2731 Iperoxo-bqca C6
Muscarinic Acetylcholine Receptor Hybrid Ligand, possessing noticeable M2/M4 mAChR selectivity
More description
DCC2730 Ipcs-1
Novel inhibitor of the plant inositol phosphorylceramide synthase ((IPCS), demonstrating herbicidal activity
More description
DCC2729 Iodoclorgyline
Selective monoamine oxidase A inhibitor
More description
DCC2728 Iodiconazole
Novel antifungal agent, exhibiting broad spectrum and potent activity against 12 kinds of clinically pathogenic fungi
More description
DCC2727 Inz-4 [1585213-98-4]
Novel Potent Fungal-Selective Inhibitor of Mitochondrial Cytochrome bc1
More description
DCC2726 Inuloxin A
Natural Activator of Programmed Cell Death, leading to membrane damage, mitochondria alteration, chromatin condensation, and ROS accumulation
More description
DCC2725 Intoplicine
Inhibitor of both topoisomerase I and II via intercalating DNA helix
More description
DCC2724 Intervenolin
Natural potent inhibitor of H. pylori DHODH, having greater efficacy for treatment of H. pylori infection
More description
DCC2723 Int2-31
Blocker of the interaction of FAK and IGF-1R; Antagonist of the phosphorylation of tumor AKT
More description
DCC2722 Ins48823
Activator of the P2Y6 receptor in bone, increasing survival of osteoclasts
More description
DCC2721 Ins3-54-a26
Novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppressing tumor growth, metastasis and STAT3 target gene expression in vivo
More description
DCC2720 Ins015_037
Novel potent inhibitor of DDR1 tyrosine kinase
More description
DCC2719 Inp1750
Novel putative inhibitor of type III secretion (T3S) in the Gram-negative pathogen Yersinia pseudotuberculosis and Chlamydia trachomatis
More description
DCC2718 Inos-in-d27
Novel Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X